Key result
Female gender is not linked to higher 30-day mortality or worse survival after CABG and AVR.
Why the study?
Women undergoing isolated CABG have increased post-operative risk, but it is unclear if this applies to concomitant CABG and AVR surgery.
Does female gender affect short- and long-term mortality in patients undergoing concomitant CABG and AVR?
Cohort (n=2,563)
Yes
Does female gender affect short- and long-term mortality in patients undergoing concomitant CABG and AVR?
Answers are grounded in this paper and cite their sources.
Female gender is not associated with poorer short- or long-term mortality after concomitant CABG and AVR surgery, despite being associated with higher rates of post-operative MI and transfusion.
OBJECTIVES: Women undergoing isolated coronary artery bypass graft (CABG) surgery have been previously shown to be at an independently increased risk for post-operative morbidity and mortality. However, there are considerably less data on whether this trend remains true in patients undergoing concomitant aortic valve replacement (AVR) and CABG surgery. The aim of our study was to investigate this pertinent issue. METHODS: Data obtained between June 2001 and December 2009 by the Australasian Society of Cardiac and Thoracic Surgeons Cardiac Surgery Database Program were retrospectively analysed. Demographic, operative data and post-operative complications were compared between male and female patients using χ(2) and t tests. Long-term survival analysis was performed using Kaplan-Meier survival curves and the log-rank test. Independent risk factors for short- and long-term mortality were identified using binary logistic and Cox regression, respectively. RESULTS: Concomitant AVR and CABG surgery was undertaken in 2,563 patients; 31.8% were female. Female patients were older (mean age 76 vs. 73 years; p < 0.001) and presented more often with hypertension (p < 0.001) but less often with severely impaired ejection fraction (p < 0.001), peripheral vascular disease (p < 0.001) and triple vessel disease (p < 0.001). Women did not demonstrate an increased risk of 30-day mortality (4.8 vs. 3.3%) on univariate (p = 0.069) or multivariate (p = 0.236) analysis. Female gender was independently associated with post-operative myocardial infarction (p = 0.022) and red blood cell transfusion (p < 0.001). There was no difference in long-term survival between men and women on multivariate analysis (p = 0.413). CONCLUSION: Female gender is not associated with poorer short- or long-term outcomes after concomitant CABG and AVR surgery.
No takes yet. Share an insight, caveat, or question.
Saxena et al. (2011) conducted a cohort in Concomitant coronary artery bypass graft (CABG) and aortic valve replacement (AVR) (n=2,563). Female gender vs. Male gender was evaluated on 30-day mortality (p=0.236). Female gender was not associated with an increased risk of 30-day mortality (4.8% vs 3.3%; P=0.236) or poorer long-term survival after concomitant CABG and AVR surgery compared to male gender.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: